John Montalbano, Director at Aritzia, holds 1.21M shares in Eupraxia Pharmaceuticals (Ticker: TSE:EPRX), holds 9.00K shares in Aritzia (Ticker: ATZAF), holds 295.00 shares in Royal Bank Of Canada (Ticker: RY). Most recently, John Montalbano Bought ― shares of Eupraxia Pharmaceuticals on Jul 02, 2024 for an estimated value of 51.80K.
What is the percentage of profitable transactions made by John Montalbano?
The percentage of profitable transactions made by John Montalbano is 78%.
What is the average return per transaction made by John Montalbano?
The average return per transaction made by John Montalbano is 84.50%.
What stocks does John Montalbano hold?
John Montalbano holds: ATZAF, RY, TSE:EPRX stocks.
What was John Montalbano’s latest transaction?
John Montalbano latest transaction was an Informative Buy of C$51.80K.
What was John Montalbano's most profitable transaction?
John Montalbano’s most profitable transaction was an Informative Buy of TSE:EPRX stock on September 8, 2022. The return on the trade was 330.10%.
What is John Montalbano's role in Aritzia?
John Montalbano's role in Aritzia is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.